Published 18 April 2005. doi:10.1084/jem.20042558
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 8, 1319-1332
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues
Laurent Abi-Rached and
Peter Parham
Department of Structural Biology, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305
CORRESPONDENCE Peter Parham: peropa{at}stanford.edu
Expression of killer cell Ig-like receptors (KIRs) diversifies human natural killer cell populations and T cell subpopulations. Whereas the major histocompatibility complex class I binding functions of inhibitory KIR are known, specificities for the activating receptors have resisted analysis. To understand better activating KIR and their relationship to inhibitory KIR, we took the approach of reconstructing their natural history and that of Ly49, the analogous system in rodents. A general principle is that inhibitory receptors are ancestral, the activating receptors having evolved from them by mutation. This evolutionary process of functional switch occurs independently in different species to yield activating KIR and Ly49 genes with similar signaling domains. Selecting such convergent evolution were the signaling adaptors, which are older and more conserved than any KIR or Ly49. After functional shift, further activating receptors form through recombination and gene duplication. Activating receptors are short lived and evolved recurrently, showing they are subject to conflicting selections, consistent with activating KIR's association with resistance to infection, reproductive success, and susceptibility to autoimmunity. Our analysis suggests a two-stage model in which activating KIR or Ly49 are initially subject to positive selection that rapidly increases their frequency, followed by negative selection that decreases their frequency and leads eventually to loss.
Abbreviations used: CYT, cytoplasmic tail; ITIM, inhibitory tyrosine-containing immunomotif; KIR, killer cell Ig-like receptor; LTK, long-tailed KIR; MYA, million yr ago; NJ, neighbor joining; STK, short-tailed KIR; TM, transmembrane domain.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Santourlidis, S., Graffmann, N., Christ, J., Uhrberg, M.
(2008). Lineage-Specific Transition of Histone Signatures in the Killer Cell Ig-Like Receptor Locus from Hematopoietic Progenitor to NK Cells. J. Immunol.
180: 418-425
[Abstract]
[Full Text]
-
Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A., Dupont, B.
(2007). KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro. J. Immunol.
179: 854-868
[Abstract]
[Full Text]
-
Guethlein, L. A., Older Aguilar, A. M., Abi-Rached, L., Parham, P.
(2007). Evolution of Killer Cell Ig-Like Receptor (KIR) Genes: Definition of an Orangutan KIR Haplotype Reveals Expansion of Lineage III KIR Associated with the Emergence of MHC-C. J. Immunol.
179: 491-504
[Abstract]
[Full Text]
-
Estefania, E., Flores, R., Gomez-Lozano, N., Aguilar, H., Lopez-Botet, M., Vilches, C.
(2007). Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets. J. Immunol.
178: 4402-4410
[Abstract]
[Full Text]
-
Kielczewska, A., Kim, H.-S., Lanier, L. L., Dimasi, N., Vidal, S. M.
(2007). Critical Residues at the Ly49 Natural Killer Receptor's Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like Protein. J. Immunol.
178: 369-377
[Abstract]
[Full Text]
-
Zhang, J., Raper, A., Sugita, N., Hingorani, R., Salio, M., Palmowski, M. J., Cerundolo, V., Crocker, P. R.
(2006). Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood
107: 3600-3608
[Abstract]
[Full Text]
-
Yawata, M., Yawata, N., Draghi, M., Little, A.-M., Partheniou, F., Parham, P.
(2006). Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med.
203: 633-645
[Abstract]
[Full Text]
-
Chiesa, S., Mingueneau, M., Fuseri, N., Malissen, B., Raulet, D. H., Malissen, M., Vivier, E., Tomasello, E.
(2006). Multiplicity and plasticity of natural killer cell signaling pathways. Blood
107: 2364-2372
[Abstract]
[Full Text]
-
Stewart, C. A., Laugier-Anfossi, F., Vely, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagne, F., Ferracci, G., Arosa, F. A., Moretta, A., Sun, P. D., Ugolini, S., Vivier, E.
(2005). Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA
102: 13224-13229
[Abstract]
[Full Text]
-
Williams, A. P., Bateman, A. R., Khakoo, S. I.
(2005). HANGING IN THE BALANCE: KIR and Their Role in Disease. Mol. Interv.
5: 226-240
[Abstract]
[Full Text]